Re: If BP buys Apabetalone,...
in response to
by
posted on
Nov 05, 2019 04:46PM
Let's also keep in mind that the RVX208 (Apebetalone) patent runs out in 2027 unless it was extended, which I'm not aware of. And it may take up to 2021 before it gets to market after FDA approval. So does a buyout of $5 billion make any sense?